Recent Articles from StockStory

Industrial processing equipment and solutions provider Hillenbrand (NYSE:HI) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 8.8% year on year to $715.9 million. On the other hand, next quarter’s revenue guidance of $576 million was less impressive, coming in 5.8% below analysts’ estimates. Its non-GAAP profit of $0.60 per share was 11.5% above analysts’ consensus estimates.

Engineered materials manufacturer Rogers (NYSE:ROG) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 10.7% year on year to $190.5 million. The company expects next quarter’s revenue to be around $197.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.27 per share was 6.6% above analysts’ consensus estimates.

Speciality material and gas containment company Luxfer (NYSE:LXFR) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 8.5% year on year to $97 million. Its non-GAAP profit of $0.23 per share was 35.3% above analysts’ consensus estimates.

Real estate data provider CoStar Group (NASDAQ:CSGP) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 11.5% year on year to $732.2 million. On the other hand, next quarter’s revenue guidance of $772.5 million was less impressive, coming in 1.8% below analysts’ estimates. Its GAAP loss of $0.04 per share was significantly below analysts’ consensus estimates.

Industrial equipment manufacturer Kadant (NYSE:KAI) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 3.9% year on year to $239.2 million. On the other hand, next quarter’s revenue guidance of $246.5 million was less impressive, coming in 6.5% below analysts’ estimates. Its non-GAAP profit of $2.10 per share was 6.9% above analysts’ consensus estimates.

Online travel agency Booking Holdings (NASDAQ:BKNG) announced better-than-expected revenue in Q1 CY2025, with sales up 7.9% year on year to $4.76 billion. Its non-GAAP profit of $24.81 per share was 41.2% above analysts’ consensus estimates.

Electronic component provider Littelfuse (NASDAQ:LFUS) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 3.5% year on year to $554.3 million. On the other hand, next quarter’s revenue guidance of $580 million was less impressive, coming in 0.9% below analysts’ estimates. Its non-GAAP profit of $2.19 per share was 21.1% above analysts’ consensus estimates.

Professional services firm Huron Consulting Group (NASDAQ:HURN) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 11.2% year on year to $404.1 million. The company expects the full year’s revenue to be around $1.62 billion, close to analysts’ estimates. Its non-GAAP profit of $1.68 per share was 45.3% above analysts’ consensus estimates.

Marine infrastructure company Orion (NYSE:ORN) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 17.4% year on year to $188.7 million. The company’s full-year revenue guidance of $825 million at the midpoint came in 1.5% above analysts’ estimates. Its non-GAAP profit of $0.01 per share was significantly above analysts’ consensus estimates.

Solar panel manufacturer First Solar (NASDAQ:FSLR) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.4% year on year to $844.6 million. On the other hand, the company’s full-year revenue guidance of $5 billion at the midpoint came in 8.9% below analysts’ estimates. Its GAAP profit of $1.95 per share was 22.1% below analysts’ consensus estimates.

Freight delivery company Werner (NASDAQ:WERN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 7.4% year on year to $712.1 million. Its non-GAAP loss of $0.12 per share was significantly below analysts’ consensus estimates.

Healthcare services company The Ensign Group (NASDAQ:ENSG). met Wall Street’s revenue expectations in Q1 CY2025, with sales up 16.1% year on year to $1.17 billion. Its non-GAAP profit of $1.52 per share was 1.9% above analysts’ consensus estimates.

Electronics manufacturing services provider Benchmark (NYSE:BHE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6.5% year on year to $631.8 million. Next quarter’s revenue guidance of $640 million underwhelmed, coming in 4.3% below analysts’ estimates. Its non-GAAP profit of $0.52 per share was 4% above analysts’ consensus estimates.

Flow control equipment manufacturer Flowserve (NYSE:FLS) announced better-than-expected revenue in Q1 CY2025, with sales up 5.2% year on year to $1.14 billion. Its non-GAAP profit of $0.72 per share was 19.6% above analysts’ consensus estimates.

Industrial and commercial distributor Global Industrial (NYSE:GIC) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $321 million. Its GAAP profit of $0.35 per share was 75% above analysts’ consensus estimates.

Safety equipment manufacturer MSA Safety (NYSE:MSA) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 1.9% year on year to $421.3 million. Its non-GAAP profit of $1.68 per share was 6.3% above analysts’ consensus estimates.

Water analytics and treatment company Veralto (NYSE:VLTO) announced better-than-expected revenue in Q1 CY2025, with sales up 6.9% year on year to $1.33 billion. The company expects next quarter’s revenue to be around $1.32 billion, close to analysts’ estimates. Its non-GAAP profit of $0.95 per share was 9.7% above analysts’ consensus estimates.

Radiation safety company Mirion (NYSE:MIR) announced better-than-expected revenue in Q1 CY2025, with sales up 4.9% year on year to $202 million. Its non-GAAP profit of $0.10 per share was 27.4% above analysts’ consensus estimates.

Data storage manufacturer Seagate (NASDAQ:STX) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 30.5% year on year to $2.16 billion. On top of that, next quarter’s revenue guidance ($2.4 billion at the midpoint) was surprisingly good and 3.7% above what analysts were expecting. Its non-GAAP profit of $1.90 per share was 9.2% above analysts’ consensus estimates.

Online education Stride (NYSE:LRN) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 17.8% year on year to $613.4 million. The company’s full-year revenue guidance of $2.38 billion at the midpoint came in 1.6% above analysts’ estimates. Its GAAP profit of $2.02 per share was 0.7% above analysts’ consensus estimates.

Recreational vehicle (RV) and boat retailer Camping World (NYSE:CWH) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3.6% year on year to $1.41 billion. Its non-GAAP loss of $0.16 per share was 21.6% above analysts’ consensus estimates.

Business software provider Freshworks (NASDAQ: FRSH) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 18.9% year on year to $196.3 million. Guidance for next quarter’s revenue was better than expected at $198.8 million at the midpoint, 0.6% above analysts’ estimates. Its non-GAAP profit of $0.18 per share was 39.4% above analysts’ consensus estimates.

Social network Snapchat (NYSE: SNAP) announced better-than-expected revenue in Q1 CY2025, with sales up 14.1% year on year to $1.36 billion. Its GAAP loss of $0.08 per share was 40.3% above analysts’ consensus estimates.

Coffeehouse chain Starbucks (NASDAQ:SBUX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 2.3% year on year to $8.76 billion. Its GAAP profit of $0.34 per share was 29.2% below analysts’ consensus estimates.

Power conversion and control solutions provider Vicor Corporation (NASDAQ:VICR) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 12% year on year to $93.97 million. Its GAAP profit of $0.06 per share was 69.2% below analysts’ consensus estimates.

Cybersecurity software maker Tenable (NASDAQ:TENB) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.7% year on year to $239.1 million. Guidance for next quarter’s revenue was better than expected at $242 million at the midpoint, 0.6% above analysts’ estimates. Its non-GAAP profit of $0.36 per share was 27.5% above analysts’ consensus estimates.

Packaged snacks company Mondelez (NASDAQ:MDLZ) met Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $9.31 billion. Its non-GAAP profit of $0.74 per share was 12.2% above analysts’ consensus estimates.

Hotel and casino entertainment company Caesars Entertainment (NASDAQ:CZR) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.9% year on year to $2.79 billion. Its GAAP loss of $0.54 per share was significantly below analysts’ consensus estimates.

Communications chips maker Qorvo (NASDAQ: QRVO) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 7.6% year on year to $869.5 million. Guidance for next quarter’s revenue was optimistic at $775 million at the midpoint, 2.4% above analysts’ estimates. Its non-GAAP profit of $1.42 per share was 41.6% above analysts’ consensus estimates.

Machinery provider H&E (NASDAQ:HEES) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 14% year on year to $319.5 million. Its non-GAAP profit of $0.03 per share was 95.5% below analysts’ consensus estimates.

Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 132% in the afternoon session after the company announced plans to make it easier for its members to access Eli Lilly's FDA-approved weight loss drug Zepbound. Given the success of weight loss drugs with regulatory approval and the crackdown on knock-offs, expanding the distribution of Zepbound should accelerate adoption. Additionally, companies such as WeightWatchers should benefit from increased sales volume and greater customer loyalty as they align themselves with medically endorsed treatments.

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 34.8% in the afternoon session after the company reported disappointing first-quarter 2025 earnings as sales fell below Wall Street's expectations. Another blemish was that while full-year revenue guidance was raised, full-year EBITDA guidance was maintained, signaling that profit margins for the year would be lower than initially expected. On the other hand, NeoGenomics beat analysts' EPS expectations, and its full-year revenue guidance exceeded Wall Street's estimates. Overall, this quarter was mixed. The areas below expectations seemed to be driving the move.

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 34.9% in the pre-market session after Novo Nordisk announced plans to offer its weight loss drug Wegovy through the company's (Hims & Hers Health's) platform, expanding access to one of its fastest-growing products. By partnering with a popular telehealth company, Novo could speed up Wegovy's adoption, leading to more prescriptions. For investors, the deal signals a clear strategy to expand distribution and grab more market share, a move that could also boost sales growth for Hims & Hers (HIMS).

Shares of HR outsourcing provider Insperity (NYSE:NSP) fell 17.2% in the morning session after the company reported underwhelming first-quarter 2025 results as it lowered its full-year guidance while missing Wall Street's EPS and EBITDA estimates. Sales grew slightly, but operating income tumbled, reflecting margin pressure. Overall, this was a softer quarter.

Shares of metal packaging products manufacturer Crown Holdings (NYSE:CCK) jumped 8.3% in the afternoon session after the company reported a nice "beat and raise" quarter. Crown Holdings blew past analysts' EPS expectations on a smaller revenue beat. Sales rose modestly by 4%, lifted by increased shipments in beverage cans. Looking ahead, the company raised its full-year EPS guidance, which was encouraging. Zooming out, we think this was a good quarter with some key areas of upside.

Shares of environmental solutions provider CECO Environmental (NASDAQ:CECO) jumped 18.3% in the afternoon session after the company reported strong first quarter 2025 results: its revenue surged past Wall Street's expectations, and adjusted EPS outpaced forecasts. The real story this quarter was a 40% jump in sales, fueled by record-breaking orders and a backlog that climbed 55%. Full-year guidance remained intact, with CECO expecting roughly 30% revenue growth and a 50% jump in adjusted EBITDA, showing confidence in its ability to execute despite macro uncertainties. Zooming out, we think this was a solid quarter.

Shares of biotech company Regeneron (NASDAQ:REGN) fell 9.6% in the morning session after the company reported weak first-quarter 2025 results. Its revenue missed significantly, and its EPS fell short of Wall Street's estimates. Revenue declined 4% from the prior year, as Regeneron struggled to offset the double-digit decline in net product sales, including a 29% plunge in legacy EYLEA, despite a 54% jump in EYLEA HD. Overall, this quarter could have been better.

Shares of hospital operator Tenet Healthcare (NYSE:THC) jumped 12.2% in the afternoon session after the company reported first-quarter 2025 results, which blew past analysts' EPS expectations on a solid revenue beat. Even though total revenue dipped a bit, that was mostly from selling off some hospitals. Looking ahead, Tenet raised its full-year adjusted EPS guidance, while keeping its revenue outlook unchanged, signaling confidence in margin expansion even without top-line acceleration. Overall, this quarter was still solid.

Shares of building materials manufacturer UFP Industries (NASDAQ:UFPI) fell 6.7% in the morning session after the company reported disappointing Q1 2025 results: revenue, EPS, and EBITDA fell short of Wall Street's estimates. Sales declined slightly, driven by lower organic unit sales and modest price declines, with particularly sharp drops in the Retail and Packaging segments, offset only partially by slight growth in Construction. Overall, this was a weaker quarter.

Shares of enterprise data capture company Zebra Technologies (NASDAQ:ZBRA) jumped 8.8% in the pre-market session after the company reported strong first-quarter 2025 results, which exceeded expectations for both organic revenue and earnings per share. The key highlight was the 12% jump in organic sales, led by 18% growth in the Asset Intelligence & Tracking segment and a solid 9% increase in Enterprise Visibility & Mobility. Despite the upbeat results, the company's full-year and next-quarter EPS outlooks fell below Wall Street's expectations, with management citing a $70 million headwind from U.S. import tariffs as a key drag on profitability. Overall, this was a mixed quarter, but the market seems to be rewarding the strong quarter and overlooking the tepid guidance.

Shares of manufacturing company Leggett & Platt (NYSE:LEG) jumped 29.7% in the afternoon session after the company reported strong first-quarter 2025 results: its revenue was in line with Wall Street's targets, while its EPS topped expectations. Despite the top-line decline, margins improved. That margin expansion, combined with cost control, helped adjusted EPS to clear analyst expectations. Overall, this was a good quarter.

Shares of chip manufacturer NXP Semiconductors (NASDAQ: NXPI) fell 8.6% in the afternoon session after the company reported mixed first-quarter 2025 results: Its inventory levels materially increased, and the next quarter's EPS guidance was just in line, seemingly not enough to excite the market. In addition, CEO Kurt Sievers announced plans to retire at the end of the year, creating more uncertainty amid tariff-induced concerns. On the other hand, NXP Semiconductors narrowly topped analysts' adjusted operating income expectations and its EPS narrowly outperformed Wall Street's estimates. Zooming out, we think this was a decent quarter featuring some areas of strength but also some blemishes.

Shares of identity management software maker Okta (OKTA) jumped 8.9% in the afternoon session after S&P Dow Jones Indices announced the company would be added to the S&P MidCap 400 before trading opens on Thursday, May 1, 2025. Being included in the index means that Okta will likely be held by many mutual funds and ETFs, which could potentially drive up demand for the stock. 

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.

Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates), and the market seems convinced that demand will slow. Due to this bearish outlook, the industry has tumbled by 11.2% over the past six months. This drawdown was worse than the S&P 500’s 5.6% loss.

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates), and the market seems convinced that demand will slow. Due to this bearish outlook, the industry has tumbled by 11.2% over the past six months. This drop was worse than the S&P 500’s 5.6% loss.

Whether you see them or not, industrials businesses play a crucial part in our daily activities. Still, their generally high capital requirements expose them to the ups and downs of economic cycles, and the market seems to be baking in a prolonged downturn as the industry has shed 11.2% over the past six months. This drop was worse than the S&P 500’s 5.6% decline.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.